#Fight4Hematology Action Hub
As the world’s largest professional society serving clinicians and scientists around the world who are working to conquer blood diseases, ASH is fighting for hematology in the face of executive orders and other federal actions that threaten hematology research and, ultimately, the care of patients.
ASH has created the #Fight4Hematology Action Hub to keep you up-to-date on ASH's efforts and provide four easy ways you can get involved to protect the future of hematology research and advances in patient care. Together, we can drive meaningful change!
Join the FightSEE LATEST NEWS AND UPDATES
ASH Commits $12 Million to Address Threats to Research
ASH has made an unprecedented investment of more than $12 million to address the sudden and massive cuts to federal research grants, training opportunities, and federal programs put in place by the new Administration. This includes a roughly $9 million increase in award funding, bringing ASH’s total awards commitment to more than $20 million over the next 12 months. This investment will provide support for an additional 600+ awardees at all career stages.
Join ASH’s Advocacy Training Webinar: Your Voice is Needed in these Challenging Times
Wednesday, June 18 from 2:00 p.m. to 3:00 p.m. ET
Your voice matters now more than ever as the Administration and Congress continue to consider the future of federal funding and programs that impact hematologic care and research. ASH continues to lead advocacy on behalf of hematologists in Washington, but we need your help to amplify the messages and share how these policies will affect your research and patient care. Learn how to effectively engage with your elected officials, understand ASH’s top policy priorities, and get the tools to influence real change.
Join the Fight
Join the #Fight4Hematology by taking four critical actions. Together, we can protect the future of hematology research and patient care.
Advocate
The future of biomedical research and health care is in jeopardy, threatening U.S. innovation and putting the lives of millions with blood disorders at risk. It is critical that the hematology community come together to opposes these changes.
Advocacy Toolkit
ASH has created an advocacy toolkit, including fact sheets, infographics, and talking points, to support discussions with legislators, serve as “leave behind” documents after meetings, and enhance written and phone communications.
Share Your Story
Make your voice heard in Congress by sharing how executive orders have impacted hematology research, patient care, and the future of treatment — because your experience can drive meaningful change.
Take ASH’s NEW Survey on NIH Funding Cuts and Delays
Take ASH’s survey to share how the Administration’s policies have impacted your research. Since the Administration took office, policies have been implemented that delay or restrict the release of appropriated funding for peer-reviewed grants, and we need to hear about how these changes are impacting you to inform ASH’s advocacy with the Administration and Congress. Take the Survey
Donate
Contribute to the ASH Foundation to support additional ASH Awards to ensure that hematologists can continue their vital research without interruption.
Support the ASH Foundation
ASH is dedicated to helping hematologists conquer blood diseases worldwide. The ASH Foundation Greatest Needs Fund helps support additional research awards including the Bridge Grant, ensuring ASH members can continue their vital work.
Let's all be that person who's going to stand up and fight for science, fight for research, fight for hematology, and fight for our patients.
News and Updates
Stay up-to-date on ASH’s advocacy work. Get the latest news, policy developments, and updates affecting the hematology community.
Testimony and Correspondence
View formal congressional testimony and correspondence related to issues affecting hematologists and their patients.
Resources
ASH fights for hematologists at all career stages through the uncertainty. These resources empower hematologists and encourage growth and innovation in hematology.